Company intelligence / Profile preview

Range Therapeutics

San Carlos, California, United States

Ownership: Private
Development stage: Other

Overview

Range Biotechnologies has developed an innovative platform for high-throughput, multiplexed protein quantification, aiming to enable precision health by providing accurate, scalable longitudinal biomarker data for diagnostics, drug development, and personalized medicine. Recent seed funding will accelerate R&D and platform commercialization

Therapeutic areas: OncologyOther
Modalities: Protein quantification platformTranslational proteomicsDiagnostic platform
Industry: Protein Biomarker Diagnostics

Partnerships

No major pharmaceutical/biotech partnerships publicly disclosed. Strategic partners sought.

Beyond the preview

Go deeper on Range Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Range Therapeutics.

Explore the full profile